However, semaglutide and tirzepatide inhibited OATP1B1/3 activity, despite their relatively large molecular size, in the absence of bovine serum albumin (BSA)
When individuals begin GLP-1 therapy, their bodies undergo several metabolic adaptations
Enhanced Cognitive Function: Supports memory, focus, and mental clarity, important for work, creativity, and everyday life
36 The next frontier: Quality weight loss The current generation of GLP-1s is fantastic at dropping weight, but a strategic vulnerability is muscle wasting. Up to 25-40% of the weight lost on these drugs can be lean muscle mass
One common theme is injection-day anxiety